Abstract
Aim To evaluate current provision of medical Same Day Emergency Care (SDEC) services within the UK, and current utilisation of these pathways in the assessment of unplanned medical attendances.
Design Survey data was used from the Society for Acute Medicine Benchmarking Audit (SAMBA), including anonymised patient-level data collected annually using a day of care survey
Setting Hospitals accepting unplanned medical attendances within the UK, 2019-2023. Participants: 34,948 unplanned and 4,342 planned attendances, across 188 hospital sites
Results 29.8% of unplanned medical attendances received their initial medical assessment within SDEC services, with the proportion increasing over time. 82.4% of patients assessed in SDEC services were discharged without overnight admission. Assessment in SDEC services was less likely in male patients, patients with frailty, and older adults (all p<0.005).
Selected operational standards for SDEC delivery were met in 64-91% of hospitals. Most hospitals (82%) accepted referrals from emergency department triage and 63% accepted referral directly from the paramedic team. 38% of hospitals did not use a recognised selection criteria to identify suitable patients for SDEC and only 8% used a criteria designed to identify patients suitable for discharge. Overall, 34.7% of medical attendances discharged without overnight admission received their medical assessment in locations other than SDEC.
Conclusions Medical SDEC provides assessment for one third of patients seen through acute medicine services. Although the proportion of patients assessed within SDEC is increasing, further innovation and improvements are needed to ensure appropriate patients access this service.
Strengths and limitations of this study
-Medical same day emergency care (SDEC) has been widely adopted in the UK to deliver care to patients without overnight hospital admission, however there is limited evidence guiding development of this service.
-This study compares hospital-level data describing SDEC service structure and processes, and patient level data for over 35,000 patient attendances at 188 hospitals in the UK.
-This is the largest evaluation of medical SDEC to date and demonstrates an increase in the use of SDEC for medical patients nationally.
-The participation rate was higher amongst hospitals in England compared to the other three UK nations, which may limit generalisability.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No specific funding was received for the study as reported here. The database used for SAMBA data collection is funded by the Society for Acute Medicine. C Atkin reports funding from the NIHR, E Sapey reports funding support from HDRUK, MRC, Wellcome Trust, NIHR, Alpha 1 Foundation, EPSRC and British Lung Foundation. This study was supported by the National Institute for Health Research (NIHR) Applied Research Collaboration (ARC) West Midlands, the NIHR Oxford Biomedical Research Centre (BRC) and NIHR HealthTech Research Centre (HRC) for Community Healthcare through salary support to D Lasserson.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Health Research Authority approval has been granted to allow secondary analysis on non-identifiable data (REC 21/HRA/4196).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data are available on reasonable request. Data from this study are available from PIONEER, the Health Data Hub in Acute care, in accordance with Hub processes. See www.pioneerdatahub.co.uk and contact PIONEER{at}uhb.nhs.uk for more details.
